doxazosin
Commercial- Indications
- Hypertension
Company intelligence / Profile preview
Unichem Laboratories Ltd
Mumbai, Maharashtra, Indiaunichemlabs.com ↗
- Ownership
- Public · UNICHEMLAB
- Employees
- ~3100
- Development stage
- Commercial
01
Overview
Unichem Laboratories is a well-established pharmaceutical company with multiple ANDA approvals from the USFDA for various products. The company has received international accreditations for its manufacturing facilities.
- Therapeutic areas
- EndocrinologyImmunologyPsychiatryGastroenterologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Small moleculesActive Pharmaceutical Ingredients (APIs)Formulations
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
Collaborations with multinational pharmaceutical organizations and generic companies
04
Financials
- Market cap
- $531.7B
- Total revenue
- $400.3B
Beyond the preview
Go deeper on Unichem Laboratories Ltd.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Unichem Laboratories Ltd.